Fluoroquinolone antibacterials enhance UVA-induced skin tumors

Journal of Photochemistry and Photobiology B: Biology

Volumn 37, Issue 3, 1997, Pages 174-181

  Klecak, Georg ^a   Urbach, Frederick ^b   Urwyler, Heinrich ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b Temple Medical Practices   (United States)

Author keywords

Fluoroquinolone antibacterials; Phototoxicity; UVA induced skin tumours

Indexed keywords

CIPROFLOXACIN; ENOXACIN; FLEROXACIN; LOMEFLOXACIN; METHOXSALEN; NALIDIXIC ACID; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; ERYTHEMA; FEMALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PHOTOTOXICITY; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET A RADIATION;

ANIMALS; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; FEMALE; FLEROXACIN; FLUOROQUINOLONES; MICE; NALIDIXIC ACID; NEOPLASMS, RADIATION-INDUCED; OFLOXACIN; QUINOLONES; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 0031081745     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1011-1344(96)07424-6     Document Type: Article

References (38)

1. [1] B.E. Johnson, Skin and related photoreactions, in G. Moreno et al. (eds.), Photosensitization, NATO ASI Series, H15 (1988) 253-264.
2. [2] A.G. Smith, Drug induced photosensitivity, Adverse Drug React. Bull., 136 (1989) 508-511.
3. [3] J. Ferguson and B.E. Johnson, Recently developed photosensitizing agents, in F. Urbach (ed.). Biological Responses to Ultraviolet A Radiation, Valenmar, Overland Park, KS, 1991, pp. 107-119.
4. [4] K. Sugiura, K. Tsuruta, H. Noda, K. Morita and Y. Umemura, Photo-induced drug eruption from enoxacin, Rinsho Derma, 29 (1987) 151-154.
5. [5] Y. Kawabe, M. Mizuno and S. Sakakibara, Photoallergic reactions caused by enoxacin, Photodermatology, 6 (1989) 57-69.
6. [6] E.D. Shelley and W.B. Shelley, The subcorneal pustular eruption: an example induced by norfloxacin, Cutis, 42 (1988) 24-27.
7. [7] R. Baran and P. Brun, Photoonycholysis induced by the fluoroquinolones pefloxacin and ofloxacin, Dermatologica, 173 (1986) 185-188.
8. [8] E.W. Granowitz, Photosensitivity rash in a patient treated with ciprofloxacin, J. Infect. Dis., 160 (1989) 910-911.
9. [9] S.T. Nedorost, J.W.E. Dijkstra and D.W. Handel, Drug-induced photosensitivity reactions. Arch. Dermatol., 125 (1989) 433-134.
10. [10] W.R. Bowie, V. Willetts and P.J. Jewesson, Adverse reactions in a dose ranging study with a new long-acting fluoroquinolone, fleroxacin, Antimicrob. Agents Chemother., 33 (1989) 1778-1782.
11. [11] M. Yoshizawa, S. Takino, A. Hashimoto, R. Asai and S. Nishiyama, A case of photo-induced drug eruption from lomefloxacin, Proc. 175th Fukuoka Dermatological Society Meet., 1990.
12. [12] J.N. Burry and R.W.L. Crosby, A case of phototoxicity to nalidixic acid, Med. J. Aust., 2 (1966) 698.
13. [13] C.A. Ramsay and E. Obreshkova, Photosensitivity from nalidixic acid, Br. J. Dermatol., 91 (1974) 523-528.
14. [14] Y. Kurumaji and M. Shono, Scarified photopatch testing in lomefloxacin photosensitivity, Contact Dermatit., 26 (1991) 5-10.
15. [15] K.H. Pfoertner, Personal Communication, Hoffmann-La Roche, Basel, 1992.
16. [16] N. Wagai and K. Tawara, Important role of oxygen metabolites in quinolone antibacterial agent-induced cutaneous phototoxicity in mice, Arch. Toxicol., 65 (1991) 495-499.
17. [17] D.G. Robertson, G.A. Epling, J.S. Kiely, D.L. Bailey and B. Song, Mechanistic studies of the phototoxic potential of PD 117596, a quinolone antibacterial compound, Toxicol. Appl. Pharmacol., 111 (1991) 221-232.
18. [18] C. Laburte and G. Klecak, Personal Communication, Hoffmann-La Roche, Basel, 1989.
19. [19] I. Nakagawa, Personal Communication, Kyorin, Tokyo, 1989.
20. [20] B.E. Johnson, N.K. Gibbs and F. Ferguson, A quinolone antibiotic with potential to photosensitive skin tumorgenesis, J. Photochem. Photobiol., in press.
21. [21] G. Klecak and J.M. Potthast, Personal Communication, Hoffmann-La Roche, Basel, 1990.
22. [22] H. van Weelden, S.C.J. van der Putte, J. Toostra and J.C. van der Leun, UVA induced tumors in pigmented hairless mice and the carcinogenic risk of tanning with UVA, Arch. Dermatol. Res., 282 (1990) 289-294.
23. [23] J.K. Dunnick, P.D. Forbes, R.E. Davies and W.O. Iverson, Toxicity of 8-methoxypsoralen, 5-methoxypsoralen, 3-carbethoxypsoralen, or 5-methyhsopsoralen with ultraviolet radiation in the hairless (HRA/ Skh) mouse, Toxicol. Appl. Pharmacol., 89 (1987) 73-80.
24. [24] P. Heizman, R. Geschke, A. Gianni and A. Guenzi, Personal Communication, Hoffmann-La Roche, Basel, 1990.
25. [25] F. Stenbäck, Life history and histopathology of ultraviolet light-induced skin tumors, Nat. Cancer Inst. Mono., 50 (1978) 57-70.
26. [26] F. Stenbäck, Cell injury and cell proliferation in skin carcinogenesis induced by UV light, Oncology, 31 (1975) 61-75.
27. [27] F. Stenbäck, Promotion in the morphogenesis of chemically inducible skin tumors, Acta Pathol. Microbiol. Scand. Suppl., 208 (1969) 1-116.
28. [28] F. Stenbäck et al., Effect of ultraviolet radiation on skin, Int. Agency Res. Cancer, 40 (1986).
29. [29] F. Stenbäck, Species-specific neoplastic progression by ultraviolet light on the skin of rats, guinea pigs, hamsters and mice, Oncology, 31 (1975) 209-212.
30. [30] M. Mäkinen, P.D. Forbes and F. Stenbäk, Quinolone antibacterials: a new class of photochemical carcinogens, J. Photochem. Photobiol., in press.
31. [31] G. Kelfkens, F.R. de Gruijl and J.C. van der Leun, Carcinogenesis by short and long wave ultraviolet A: papilloma versus squamous cell carcinoma, in F. Urbach (ed.), Biological Responses to ultraviolet A Radiation, Valdemar, Overland Park, KS, 1992.
32. [32] E.L. Kaplan and P. Meier, Non-parameter estimation from incomplete observations, J. Am. Stat. Assoc., 53 (1958) 457-481.
33. [33] R. Peto, M.C. Pike, N.E. Day et al., Guidelines for simple sensitive significance tests for carcinogenic effects in long-term animal experiments, IARC Mono. Eval. Carcinogen, Risk Chem. Humans, Suppl., 2 (1980) 311-426.
34. [34] T. Hsu, P.D. Forbes, L.C. Harber and E. Lakow, Induction of skin tumors in hairless mice following a single exposure to ultraviolet radiation, Photochem. Photobiol., 21 (1975) 185-188.
35. [35] Photobiologic, toxicologic and pharmacologic aspects of psoralens, NCI Mono., 66, NIH Publ., 84-2692, USDHHS, PHS, NIH, Bethesda, MD, 1984.
36. [36] R.S. Stern, PUVA: its status in the United States 1988, in T.B. Fitzpatrick, P. Forlot, M.A. Pathak and F. Urbach (eds.), Psoralen; Past, Present and Future, John Libby Eurotext, London, 1989, pp. 367-373.
37. [37] T. Henseler, E. Christophers, H. Hönigsmann et al., Skin tumors in the European PUVA study, J. Am. Acad. Dermatol., 16 (1987) 108-116.
38. [38] B. Beretti, R. Triller, I. Tardy and C. Grupper, Chronic effects of oral photochemotherapy: results of retrospective study at a single centre, in T.B. Fitzpatrick, P. Forlot, M.A. Pathak and F. Urbach (eds.), Les Psoralenes en 1991, John Libby Eurotext, London, 1991, p. 63.